The FDA just approved a drug for lupus patients despite the fact that it could be deadly.

Benlysta is the first new drug approved for treating lupus in 56 years – but it shouldn’t have been. Because while study results “suggested, but did not definitively establish” that the drug might reduce severe flare-ups of disease symptoms, researchers reported a higher death rate in the patients taking Benlysta.

This comes straight off the FDA announcement:
Those receiving Benlysta during clinical studies reported more deaths and serious infections compared with placebo.

The FDA approved this obviously dangerous and potentially deadly drug. Your doctor may recommend Benlysta. But you don’t have to take it. Because as horrific as lupus symptoms can be, serious infections and death are worse.

Allan Spreen, M.D.
Dr. Allan Spreen, Chief Medical Advisor

Meet the Health Sciences Institute

The Health Sciences Institute (HSI) is an independent organization established in 1998. We’re dedicated to uncovering and researching the most urgent advances in modern underground medicine. Things you WON’T hear about in the mainstream.

Whether they come from a laboratory in Malaysia, a clinic in South America, or a university in Germany, our goal is to bring the treatments that work directly to the people who need them. We alert our Members to exciting breakthroughs in medicine, show them exactly where to go to learn more, and help them understand how they and their families can benefit from these powerful discoveries.

Learn More About the Health Sciences Institute. >